CDKN2A deletion in p16-negative/HPV-positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement
Histopathology. 2025 Oct 9. doi: 10.1111/his.70021. Online ahead of print. ABSTRACT AIMS: Immunohistochemistry (IHC) for p16 is widely used as a surrogate marker for HPV …